Biosimilar of etanercept (Enbrel).

Permethrin induces electrochemical abnormalities across the membranes of the excitable cells of susceptible parasites. This leads to sensory hyper-excitability, lack of coordination and prostration.

Secukinumab is a fully human IgG1/k; monoclonal antibody that selectively binds to and neutralises the proinflammatory cytokine interleukin-17A (IL-17A). Secukinumab works by targeting IL-17A and inhibiting its interaction with the IL-17 receptor, which is expressed on various cell types including keratinocytes. As a result, secukinumab inhibits the release of proinflammatory cytokines, chemokines and mediators of tissue damage and reduces IL-17A-mediated contributions to autoimmune and inflammatory diseases. Clinically relevant levels of secukinumab reach the skin and reduce local inflammatory markers. As a direct consequence treatment, secukinumab reduces erythema, induration and desquamation present in plaque psoriasis lesions.

Advanced range of elasticated viscose stockinette.

Elasticated viscose stockinette.

Dressing retention and garment for wet and dry wrapping in the treatment of atopic eczema.

Liquid paraffin light 60mg per 1g and white soft paraffin 150mg per 1g

Liquid paraffin light 60mg per 1g and white soft paraffin 150mg per 1g

Liquid paraffin light 105mg per 1g and white soft paraffin 132mg per 1g

A spray-on emollient, applying a mix of pure White Soft Paraffin BP and Liquid Paraffin BP to the skin. Free from water, fragrance, SLS, lanolin, parabens and preservatives. Spray-on delivery allows hands-free application, ideal for tender, vulnerable skin and hard-to-reach places.